The market for antiparasitic products comprises the largest segment for sal
es of livestock and companion-animal healthcare agents. Despite the availab
ility of highly effective, broad-spectrum agents, there remains a need for
safer, more convenient and more environmentally friendly products that will
overcome the ever-present threat of resistance development. The very high
cost of discovering and developing a new drug, especially for use in livest
ock, is reflected in the limited number of new classes of antiparasitic age
nt launched on the market. New strategies are being adopted to minimise the
cost of discovering potential drug candidates by maximising the chance of
identifying a useful target mechanism of action and by speeding the time to
discover and optimise a lead structure. These rely heavily on new technolo
gies in target identification, screen development and lead optimisation. Ex
amples of these will be discussed and speculation made about the possible f
actors that could influence the future shape of antiparasitic control. (C)
1998 Australian Society for Parasitology. Published by Elsevier Science Ltd
. All rights reserved.